Contreras ZE, Gómez MJE, Zuluaga MSX

Language: Spanish
References: 10
Page: 93-97
PDF size: 208.42 Kb.

ABSTRACT

The pulseless electrical activity (PEA) is defined as the presence of cardiac electrical activity organized without translated into mechanical activity (lack of central arterial pulse) or TAS ‹ 60 mmHg. It is the main cause of cardiac arrest hospitalized patient. The etiology is variable, but is to identify the cause of arrhythmia and start a therapeutic fast and effective, to restore the patient to achieve a rate of perfusion. Below is a clinical case of PEA secondary to massive pulmonary embolism, one of the 12 leading causes this arrhythmia, which was handled in accordance with the current international and guides, as the effectiveness of thrombolysis in this scenario has little effect, it was putting into extracorporea circulation for a later performed trombectomia. This case is of interest because it open a therapeutic option for this group of patients.

REFERENCES

1. American Heart Association. 2005 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) Science With Treatment Recommendations Circulation. Volume 112, Issue 22 Supplement; November 29, 2005.

2. Dager WE. Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy. 2006; 26(12): 1703-1729.

3. Spohr F. Drug treatment and thrombolytics during cardiopulmonary resuscitation. Curr Opin Anaesthesiol 2006; 19(2): 157-165.

4. Abu RB. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 346(20): 1522-1528.

5. Anderson J. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007; 115(20): 2637-2641.

6. Gossage JR. Early intervention in massive pulmonary embolism. A guide to diagnosis and triage for the critical first hour. Postgrad Med 2002; 111(3): 27-8, 33-4, 39-40.

7. Goyal D. Pulmonary embolism: an unsuspected killer. Emerg Med Clin North Am 2004; 22(4): 961-983.

8. Schreiber W, Gabriel D, Sterz F, Muellner M, Kuerkciyan I, Holzer M et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 2002; 52: 63-69.

9. Spohr F, Bottiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf 2003; 26: 367-379.

10. Ruiz BM, Aguayo de Hoyos E, Serrano CMC, Díaz CMA, Fierro RJL, Ramos CJA et al. Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. Resuscitation 2001; 51:97-101.